Avid Bioservices Inc (CDMO)

[mskatiescarletohara]

Oxigene's Yearend CC tomorrow, I expect them to provide an update on their clinical studies, along with future objectives.

OXiGENE Invites Public to Listen to Fourth-quarter and Year-end 2003 Financial Results Conference Call
Wednesday January 21, 8:31 am ET
Streaming Audio of February 12 Call Will Be Available at www.oxigene.com


WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 21, 2004-- OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a leader in the development of biopharmaceutical compounds designed to target aberrant blood vessels in solid tumor cancers and ocular neovascular diseases, invites the public to listen to a live audio webcast of the Company's fourth-quarter and year-end 2003 financial results conference call at 10:00 a.m. ET Thursday, February 12, 2004. The call will be hosted by Fred Driscoll, OXiGENE's president and chief executive officer, and Dai Chaplin, Ph.D., chief scientific officer.
OXiGENE plans to announce its fourth-quarter and year-end 2003 financial results on February 12, prior to the opening of the NASDAQ Stock Market.

To listen to a live or an archived version of the webcast, please log on to the Company's Web site, www.oxigene.com. Under the "Investor Center" tab, click on the link to "Presentations & Conference Calls."

OXiGENE's fourth-quarter and year-end conference call also can be heard live by dialing 800-289-0508 (domestic) or 913-981-5550 (international) five minutes prior to the call. A continuous replay will be available beginning approximately two hours after the call and ending at midnight ET Wednesday, February 18, 2004. To access the replay, dial 888-203-1112 (domestic) or 719-457-0820 (international) and refer to reservation number 733731.